These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

941 related items for PubMed ID: 19670379

  • 1. Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS.
    Chen M, Chen G, Nie H, Zhang X, Niu X, Zang YC, Skinner SM, Zhang JZ, Killian JM, Hong J.
    Eur J Immunol; 2009 Sep; 39(9):2525-36. PubMed ID: 19670379
    [Abstract] [Full Text] [Related]

  • 2. IFN-beta inhibits human Th17 cell differentiation.
    Ramgolam VS, Sha Y, Jin J, Zhang X, Markovic-Plese S.
    J Immunol; 2009 Oct 15; 183(8):5418-27. PubMed ID: 19783688
    [Abstract] [Full Text] [Related]

  • 3. Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses.
    Nizri E, Irony-Tur-Sinai M, Lory O, Orr-Urtreger A, Lavi E, Brenner T.
    J Immunol; 2009 Nov 15; 183(10):6681-8. PubMed ID: 19846875
    [Abstract] [Full Text] [Related]

  • 4. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M, Schreiner B, Kieseier BC, Neuhaus O, Dichgans J, Hartung HP, Weller M, Wiendl H.
    J Neuroimmunol; 2005 Feb 15; 159(1-2):155-64. PubMed ID: 15652415
    [Abstract] [Full Text] [Related]

  • 5. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B, Mitsdoerffer M, Kieseier BC, Chen L, Hartung HP, Weller M, Wiendl H.
    J Neuroimmunol; 2004 Oct 15; 155(1-2):172-82. PubMed ID: 15342209
    [Abstract] [Full Text] [Related]

  • 6. Beta interferon restricts the inflammatory potential of CD4+ cells through the boost of the Th2 phenotype, the inhibition of Th17 response and the prevalence of naturally occurring T regulatory cells.
    Martín-Saavedra FM, González-García C, Bravo B, Ballester S.
    Mol Immunol; 2008 Sep 15; 45(15):4008-19. PubMed ID: 18639934
    [Abstract] [Full Text] [Related]

  • 7. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC, Lalor SJ, Lynch MA, Mills KH.
    Brain Behav Immun; 2010 May 15; 24(4):641-51. PubMed ID: 20138983
    [Abstract] [Full Text] [Related]

  • 8. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production.
    Xie L, Li XK, Funeshima-Fuji N, Kimura H, Matsumoto Y, Isaka Y, Takahara S.
    Int Immunopharmacol; 2009 May 15; 9(5):575-81. PubMed ID: 19539560
    [Abstract] [Full Text] [Related]

  • 9. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
    Ochi H, Feng-Jun M, Osoegawa M, Minohara M, Murai H, Taniwaki T, Kira J.
    J Neurol Sci; 2004 Jul 15; 222(1-2):65-73. PubMed ID: 15240198
    [Abstract] [Full Text] [Related]

  • 10. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
    Skundric DS, Dai R, Zakarian VL, Bessert D, Skoff RP, Cruikshank WW, Kurjakovic Z.
    J Neurosci Res; 2005 Mar 01; 79(5):680-93. PubMed ID: 15682385
    [Abstract] [Full Text] [Related]

  • 11. Long-term favorable response to interferon beta-1b is linked to cytokine deviation toward the Th2 and Tc2 sides in Japanese patients with multiple sclerosis.
    Mei FJ, Osoegawa M, Ochi H, Minohara M, Nan S, Murai H, Ishizu T, Taniwaki T, Kira J.
    J Neurol Sci; 2006 Jul 15; 246(1-2):71-7. PubMed ID: 16581087
    [Abstract] [Full Text] [Related]

  • 12. IFN-β regulates Th17 differentiation partly through the inhibition of osteopontin in experimental autoimmune encephalomyelitis.
    Zhao Q, Cheng W, Xi Y, Cao Z, Xu Y, Wu T, Li C, Niu X, Chen G.
    Mol Immunol; 2018 Jan 15; 93():20-30. PubMed ID: 29127843
    [Abstract] [Full Text] [Related]

  • 13. Effects of IFN-beta, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls.
    Vanderlocht J, Hendriks JJ, Venken K, Stinissen P, Hellings N.
    J Neuroimmunol; 2006 Aug 15; 177(1-2):189-200. PubMed ID: 16797728
    [Abstract] [Full Text] [Related]

  • 14. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
    Kebir H, Ifergan I, Alvarez JI, Bernard M, Poirier J, Arbour N, Duquette P, Prat A.
    Ann Neurol; 2009 Sep 15; 66(3):390-402. PubMed ID: 19810097
    [Abstract] [Full Text] [Related]

  • 15. Shifting therapeutic attention in MS to osteopontin, type 1 and type 2 IFN.
    Steinman L.
    Eur J Immunol; 2009 Sep 15; 39(9):2358-60. PubMed ID: 19681057
    [Abstract] [Full Text] [Related]

  • 16. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
    Rojo JM, Pini E, Ojeda G, Bello R, Dong C, Flavell RA, Dianzani U, Portolés P.
    Int Immunol; 2008 Apr 15; 20(4):577-89. PubMed ID: 18310064
    [Abstract] [Full Text] [Related]

  • 17. T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta.
    Durelli L, Conti L, Clerico M, Boselli D, Contessa G, Ripellino P, Ferrero B, Eid P, Novelli F.
    Ann Neurol; 2009 May 15; 65(5):499-509. PubMed ID: 19475668
    [Abstract] [Full Text] [Related]

  • 18. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
    Hamamcioglu K, Reder AT.
    Mult Scler; 2007 May 15; 13(4):459-70. PubMed ID: 17463069
    [Abstract] [Full Text] [Related]

  • 19. Upregulation of interferon-gamma and interleukin-4, Th cell-derived cytokines by So-Shi-Ho-Tang (Sho-Saiko-To) occurs at the level of antigen presenting cells, but not CD4 T cells.
    Kang H, Choi TW, Ahn KS, Lee JY, Ham IH, Choi HY, Shim ES, Sohn NW.
    J Ethnopharmacol; 2009 May 04; 123(1):6-14. PubMed ID: 19429332
    [Abstract] [Full Text] [Related]

  • 20. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
    Jee Y, Liu R, Bai XF, Campagnolo DI, Shi FD, Vollmer TL.
    Int Immunol; 2006 Apr 04; 18(4):537-44. PubMed ID: 16481342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.